|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
ocn847450495 |
| 003 |
OCoLC |
| 005 |
20240623213015.0 |
| 006 |
m o d |
| 007 |
cr cnu---mpcbr |
| 008 |
091204s2008 nyu ob 001 0 eng d |
| 040 |
|
|
|a AU@
|b eng
|e pn
|c AU@
|d E7B
|d OCLCQ
|d EBLCP
|d MNM
|d DEBSZ
|d CSJ
|d OCLCO
|d OCLCF
|d OCLCQ
|d AZK
|d MERUC
|d MOR
|d PIFAG
|d ZCU
|d OCLCQ
|d U3W
|d STF
|d WRM
|d COCUF
|d NRAMU
|d ICG
|d INT
|d VT2
|d AU@
|d OCLCQ
|d WYU
|d OCLCQ
|d DKC
|d OCLCQ
|d UKCRE
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 961567804
|a 962706592
|a 988414013
|a 992070662
|a 1037903429
|a 1038635299
|a 1045515262
|a 1055407562
|a 1058135283
|a 1081282231
|a 1153491839
|a 1228584574
|
| 020 |
|
|
|a 1604564741
|
| 020 |
|
|
|a 9781604564747
|
| 020 |
|
|
|a 9781616685805
|
| 020 |
|
|
|a 1616685808
|
| 020 |
|
|
|z 9781604564747
|
| 024 |
3 |
|
|a 9781604564747
|
| 035 |
|
|
|a (OCoLC)847450495
|z (OCoLC)961567804
|z (OCoLC)962706592
|z (OCoLC)988414013
|z (OCoLC)992070662
|z (OCoLC)1037903429
|z (OCoLC)1038635299
|z (OCoLC)1045515262
|z (OCoLC)1055407562
|z (OCoLC)1058135283
|z (OCoLC)1081282231
|z (OCoLC)1153491839
|z (OCoLC)1228584574
|
| 037 |
|
|
|b 00056522
|
| 050 |
|
4 |
|a QH588.S83
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Taupin, Phillippe.
|
| 245 |
1 |
0 |
|a Stem Cells and Regenerative Medicine :
|b Volume III: Pharmacology and Therapy.
|
| 260 |
|
|
|a Hauppauge :
|b Nova Science Publishers, Incorporated,
|c Jan. 2008.
|
| 300 |
|
|
|a 1 online resource (electronic text)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 520 |
8 |
|
|a Annotation.
|b Stem Cells and Regenerative Medicine, Volumes I, II, and III, present an overview and in-depth analysis of recent developments in stem cell research and therapy in a compilation of recently-published, peer-reviewed articles.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a STEM CELLS AND REGENERATIVE MEDICINE, VOLUME III: PHARMACOLOGY AND THERAPY ; STEM CELLS AND REGENERATIVE MEDICINE, VOLUME III: PHARMACOLOGY AND THERAPY; CONTENTS; PREFACE ; INTRODUCTION ; REFERENCES ; NEUROGENESIS AND ALZHEIMER'S DISEASE; ABSTRACT ; 1. INTRODUCTION; 2. NEUROGENESIS IN ALZHEIMER'S DISEASE ; 3. EFFECT ON NEUROGENESIS OF DRUGS USED TO TREAT AD ; 4. STEM CELL THERAPY FOR THE TREATMENT OF AD ; 5. CONCLUSION; ACKNOWLEDGMENTS ; REFERENCES ; NEUROGENESIS AND THE EFFECT OF ANTIDEPRESSANTS ; ABSTRACT; 1. INTRODUCTION.
|
| 505 |
8 |
|
|a 2. NEUROGENESIS CONTRIBUTES TO THE THERAPEUTIC EFFECTS OF ANTIDEPRESSANTS 3. A NEUROGENIC THEORY OF DEPRESSION ; 4. CONCLUSION ; ACKNOWLEDGMENTS; REFERENCES; ADULT NEURAL STEM CELLS AND CELLULAR THERAPY; ABSTRACT ; 1. INTRODUCTION ; 2. ADULT NEUROGENESIS AND NEURAL STEM CELLS; 3. ADULT NEURAL STEM CELLS AND CELLULAR THERAPY; 4. ADULT NEURAL STEM CELLS: A MODEL OF CHOICE FOR CELLULAR THERAPY FOR CNS DISEASES AND INJURIES ; 5. CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; STEM CELL ENGINEERING FOR CELL-BASED THERAPY; ABSTRACT ; 1. INTRODUCTION.
|
| 505 |
8 |
|
|a 2. CELL ENGINEERING TO DERIVE ESCS WITHOUT THE DESTRUCTION OF EMBRYOS 3. ADULT NEURAL STEM CELL ENGINEERING ; 4. CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; HUCNS-SC STEM CELLS; SUMMARY ; ABSTRACT ; 1. INTRODUCTION ; 2. SYNTHESIS AND SAR; 3. PRECLINICAL DEVELOPMENT; 4. METABOLISM AND PHARMACOKINETICS ; 5. TOXICITY ; 6. CLINICAL DEVELOPMENT ; 7. SIDE EFFECTS AND CONTRAINDICATIONS ; 8. PATENT SUMMARY ; 9. CURRENT OPINION ; 10. LICENSING ; 11. DEVELOPMENT HISTORY ; 12. LITERATURE CLASSIFICATIONS ; 13. ASSOCIATED PATENT ; ACKNOWLEDGMENTS ; REFERENCES.
|
| 505 |
8 |
|
|a OTI-010 OSIRIS THERAPEUTICS/JCR PHARMACEUTICALS ABSTRACT ; 1. INTRODUCTION ; 2. SYNTHESIS AND SAR ; 3. PRECLINICAL DEVELOPMENT ; 4. METABOLISM AND PHARMACOKINETICS ; 5. TOXICITY ; 6. CLINICAL DEVELOPMENT ; 7. SIDE EFFECTS AND CONTRAINDICATIONS ; 8. PATENT SUMMARY ; 9. CURRENT OPINION ; 10. LICENSING ; 11. DEVELOPMENT HISTORY; 12. LITERATURE CLASSIFICATIONS ; 13. ASSOCIATED PATENT; ACKNOWLEDGMENTS ; REFERENCES ; ADA-TRANSDUCED HEMATOPOIETIC STEM CELL THERAPY FOR ADA-SCID ; SUMMARY ; ABSTRACT ; 1. INTRODUCTION ; 2. SYNTHESIS AND SAR ; 3. PRECLINICAL DEVELOPMENT.
|
| 505 |
8 |
|
|a 4. METABOLISM AND PHARMACOKINETICS 5. TOXICITY ; 6. CLINICAL DEVELOPMENT ; 7. SIDE EFFECTS AND CONTRAINDICATIONS ; 8. PATENT SUMMARY ; 9. CURRENT OPINION ; 10. DEVELOPMENT HISTORY ; 11. LITERATURE CLASSIFICATIONS ; ACKNOWLEDGMENTS ; REFERENCES ; THERAPEUTIC POTENTIAL OF ADULT NEURAL STEM CELLS; ABSTRACT; 1. INTRODUCTION ; 2. NEURAL PROGENITOR AND STEM CELLS; 3. THERAPEUTIC POTENTIAL OF ADULT NSCS; 4. CURRENT AND FUTURE DEVELOPMENTS; ACKNOWLEDGEMENTS ; REFERENCES ; CONCLUSION AND PERSPECTIVES: ADULT NEURAL STEM CELLS -- THE PROMISE OF THE FUTURE; ABSTRACT ; 1. INTRODUCTION.
|
| 650 |
|
0 |
|a Stem cells.
|
| 650 |
|
0 |
|a Regenerative medicine.
|
| 650 |
|
7 |
|a Regenerative medicine
|2 fast
|
| 650 |
|
7 |
|a Stem cells
|2 fast
|
| 758 |
|
|
|i has work:
|a Pharmacology and therapy Stem cells and regenerative medicine Volume 3 (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGDgrH8Bx6trf8rQv8YFJC
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=3019923
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|